References
- VANE JR: Inhibition of prostaglandin synthesis as amechanism of action for aspirin-like drugs. Nature (1971) 231:232–237.
- SMITH WL, DEWITT DL: Differential interactions of pro-staglandin endoperoxide synthases with nonsteroidal antlinflammatory drugs. Curr. Opin. Invest. Drugs (1994) 3:1–11.
- VANE JR: Towards a better aspirin. Nature (1994)367:215–216.
- FUTAKI N, TAKAHSHI M, YOKOYAMA I, HIGUCHI S,OTOMA S: NS-398, a new antiinflammatory agent, selec-tively inhibits prostaglandin G/H synthase/cyclooxy-genase (COX-2) activity in vitro. Prostaglandins (1994) 47:55–59.
- WILKERSON W, GALBRAITH W, GANS-BRANGS K, GRUBB M, HEWES WE, JAFFE B, KENNEY JP, KERR J, WONG N: Antiinflammatory 4,5-diarylpyrroles: Synthesis and QSAR. J. Med. Chem. (1994) 37:988–998.
- ISAKSON P: Abstracts of papers. 208th National Meeting of the American Chemical Society, Washington, D.C.; Ameri-can Chemical Society: Washington D.C.1994; MEDI270.
- REITZ DB, LI JJ, NORTON MB, REINHARD EJ, PENICK MA, COLLINS JT, LOGUSH EW, GARLAND DJ, CHAMBERLIN TS, HUANG H-C, ISAKSON P, SEIBERT K, KOBOLDT C, GRE-GORY S, VEENHUIZEN A, ZHANG Y, ANDERSON G, PERKINS W, CASLER J, PONTE C: Abstracts of papers. 208th National Meeting of the American Chemical Society, Washington D.C.; American Chemical Society: Washington D.C. 1994; MEDI271.
- PRASIT P: Abstracts of papers. 208th National Meeting of the American Chemical Society, Washington D.C.; American Chemical Society: Washington D.C. 1994; MEDI272.
- LI C-S, BOILY C, BLACK C, CHAN C-C, FORD-HUTCHINSON AW, GUAY D, KARGMAN S, LAU CK, MANCINI J, OUIMET N, PRASIT P, ROY B, ROY P, SCHELGETZ J, TAGARI P, VICKERS P, WONG E, YOUNG RN, ZAMBONI R: Abstracts of papers. 208th National Meeting of the American Chemical Society, Washington D.C., American Chemical Society: Wash-ington D.C., 1994; mEDn16.